<?xml version="1.0" encoding="UTF-8"?>
<p id="p0270">G4-mediated antiviral drugs could represent a striking turning point in the management of viral infectious diseases, especially in people who cannot access immunization, such as immunocompromised and elderly people. Finally, the G4-mediated antiviral effects observed in latent systems may lead to cutting-edge therapeutic approaches in the treatment of human deadly malignancies, such as AIDS, herpes- and HPV-related cancers.</p>
